Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

PER ANDERSEN FYSIOTERAPI ApS

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2016 2016/9 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6%   Bankruptcy risk   5.5% 6.8% 8.4% 3.7% 10.1% 41.6% 9.7% 5.4%   Credit score (0-100)   44 37 31 53 24 0 25 41   Credit rating   BBB BBB BB BBB BB C BB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2016/9 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Net sales   0 0 0 0 3,040 3,081 3,081 3,081   Gross profit   1,507 1,595 1,519 1,959 1,055 7,369 0.0 0.0   EBITDA   306 293 68.7 483 -12.5 5,760 0.0 0.0   EBIT   133 96.1 -158 241 -217 5,760 0.0 0.0   Pre-tax profit (PTP)   72.3 40.7 -217.0 177.7 -277.4 5,748.3 0.0 0.0   Net earnings   54.7 25.0 -172.2 137.3 -216.5 4,483.6 0.0 0.0   Pre-tax profit without non-rec. items   72.3 40.7 -217 178 -277 5,748 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2016/9 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Tangible assets total   556 530 459 302 97.0 0.0 0.0 0.0   Shareholders equity total   273 247 -25.1 112 -104 4,379 4,299 4,299   Interest-bearing liabilities   667 593 723 948 1,031 0.0 0.0 0.0   Balance sheet total (assets)   1,266 1,163 1,085 1,581 1,696 5,754 4,299 4,299   Net Debt   558 562 708 933 1,031 -619 -4,299 -4,299     See the entire balance sheet 1000.0 Volume  2016 2016/9 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Net sales   0 0 0 0 3,040 3,081 3,081 3,081   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 1.3% 0.0% 0.0%   Gross profit   1,507 1,595 1,519 1,959 1,055 7,369 0.0 0.0   Gross profit growth   0.0% 5.8% -4.8% 29.0% -46.1% 598.7% -100.0% 0.0%   Employees   0 2 2 2 2 3 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 50.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,266 1,163 1,085 1,581 1,696 5,754 4,299 4,299   Balance sheet change%   0.0% -8.2% -6.7% 45.7% 7.3% 239.2% -25.3% 0.0%   Added value   305.6 293.4 68.7 482.9 24.4 5,759.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.8% 187.0% 0.0% 0.0%   Investments   383 -223 -298 -399 -409 -97 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0   EBIT trend   1.0 2.0 -1.0 1.0 -1.0 1.0 0.0 0.0   1000.0 Profitability  2016 2016/9 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% -0.4% 187.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% -7.1% 187.0% 0.0% 0.0%   EBIT to gross profit (%)   8.8% 6.0% -10.4% 12.3% -20.6% 78.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% -7.1% 145.5% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% -0.4% 145.5% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% -9.1% 186.6% 0.0% 0.0%   ROA %   10.5% 7.9% -13.9% 18.6% -11.9% 153.6% 0.0% 0.0%   ROI %   14.1% 10.8% -20.2% 28.1% -19.3% 214.5% 0.0% 0.0%   ROE %   20.1% 9.6% -25.9% 22.9% -23.9% 147.6% 0.0% 0.0%   1000.0 Solidity  2016 2016/9 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Equity ratio %   21.5% 21.2% -2.3% 7.1% -5.8% 76.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 59.2% 44.6% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 59.2% 24.5% -139.6% -139.6%   Net int. bear. debt to EBITDA, %   182.8% 191.5% 1,029.9% 193.2% -8,241.7% -10.7% 0.0% 0.0%   Gearing %   244.6% 239.9% -2,875.6% 845.6% -989.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   18.2% 8.8% 9.0% 8.7% 7.6% 10.4% 0.0% 0.0%   1000.0 Liquidity  2016 2016/9 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Quick Ratio   1.0 0.7 0.7 1.2 1.1 26.5 0.0 0.0   Current Ratio   1.0 0.7 0.7 1.2 1.1 26.5 0.0 0.0   Cash and cash equivalent   108.5 30.8 15.5 15.4 0.1 618.6 0.0 0.0   1000.0 Capital use efficiency  2016 2016/9 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 43.6 1.5 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 44.7% 186.8% 139.6% 139.6%   Net working capital   -10.6 -140.9 -204.8 155.5 71.1 5,536.6 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 2.3% 179.7% 0.0% 0.0%   1000.0 Employee efficiency  2016 2016/9 2017 2017/9 2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 1,520 1,027 0 0   Added value / employee   0 147 34 241 12 1,920 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 147 34 241 -6 1,920 0 0   EBIT / employee   0 48 -79 121 -109 1,920 0 0   Net earnings / employee   0 12 -86 69 -108 1,495 0 0